WallStreetZenWallStreetZen

AnalystsZegbeh Jallah
Zegbeh Jallah's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Top 1%
#21 out of 4176 analysts
Average Return
+100.97%
Win Rate
26%5 out of 19
Risk vs Reward
Poor
Good

Zegbeh Jallah's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Ocugen IncOCGN
+2,086.21%$0.29$6.34
2020-11-17 -
2021-06-11
Strong Buy
Ideaya Biosciences IncIDYA
+469.48%$4.03$22.95
2020-03-13 -
2021-03-12
Strong Buy
Rapt Therapeutics IncRAPT
+13.94%$16.93$19.29
2020-04-13 -
2021-04-13
Strong Buy
Clearside Biomedical IncCLSD
+12.08%$2.07$2.32
2020-05-13 -
2021-05-13
Strong Buy
Enanta Pharmaceuticals IncENTA
+9.38%$51.29$56.10
2020-08-28 -
2021-08-27
Strong Buy

Zegbeh Jallah Analyst Color

Get additional color on Zegbeh Jallah's coverage of popular stocks

Zegbeh Jallah's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Ideaya Biosciences IncIDYA
2Buy$29.00+111.22%Initiates Coverage On
3 months ago
Rapt Therapeutics IncRAPT
2Buy$48.00+161.58%Initiates Coverage On
6 months ago
Enanta Pharmaceuticals IncENTA
2Strong Buy$70.00+73.10%Maintains
a year ago
Syros Pharmaceuticals IncSYRS
1Strong Buy$230.00N/AMaintains
2 years ago
Atyr Pharma IncLIFE
2Strong Buy$21.00N/AMaintains
2 years ago
Rezolute IncRZLT
1Strong Buy$21.00N/AInitiates Coverage On
2 years ago
Arvinas IncARVN
1Strong Buy$135.00N/AMaintains
2 years ago
Dare Bioscience IncDARE
1Strong Buy$11.00N/AMaintains
2 years ago
Ocugen IncOCGN
2Hold$6.00N/ADowngrades
2 years ago
Kodiak Sciences IncKOD
2Strong Buy$149.00N/AUpgrades
2 years ago
Kalvista Pharmaceuticals IncKALV
1Strong Buy$55.00N/AMaintains
2 years ago
Applied Genetic Technologies CorpAGTC
2Strong Buy$35.00N/AMaintains
2 years ago
Clearside Biomedical IncCLSD
1Strong Buy$8.00N/AInitiates Coverage On
3 years ago
X4 Pharmaceuticals IncXFOR
1Strong Buy$20.00N/AInitiates Coverage On
3 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.